← Back to patent-cliff list

CAS 2295-31-0

thiazolidine-2,4-dione

Codes: LOBE-008, PIOG-012, HYPIL-008

Application context (from source-drug indications)

Type 2 diabetesLobeglitazone SulfateGastroparesisLobeglitazone SulfateRenal impairmentLobeglitazone SulfateAbnormal liver functionLobeglitazone SulfateType 2 diabetesAlogliptin Benzoate/Pioglitazone HydrochlorideType 2 diabetesPioglitazone HydrochloridePulmonary hypertensionPioglitazone HydrochlorideBreast cancerPioglitazone HydrochlorideNon-alcoholic steatohepatitisPioglitazone HydrochlorideCocaine addictionPioglitazone HydrochlorideAlcohol abusePioglitazone Hydrochloride肾上腺脑白质营养不良LeriglitazoneFriedreich's ataxiaLeriglitazone

Source drugs (routes using this intermediate)

DrugTierExpiry
Lobeglitazone SulfateTier C — Watch / trade-
Alogliptin Benzoate/Pioglitazone HydrochlorideTier C — Watch / trade-
Pioglitazone HydrochlorideTier B — Position early-
LeriglitazoneTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.